Your browser doesn't support javascript.
loading
Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions.
Pradeep, C -R; Zeisel, A; Köstler, W J; Lauriola, M; Jacob-Hirsch, J; Haibe-Kains, B; Amariglio, N; Ben-Chetrit, N; Emde, A; Solomonov, I; Neufeld, G; Piccart, M; Sagi, I; Sotiriou, C; Rechavi, G; Domany, E; Desmedt, C; Yarden, Y.
  • Pradeep C-; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
  • Zeisel A; Department of Systems Biology, The University of Texas MD Anderson Cancer Centre, Houston, TX, USA.
  • Köstler WJ; Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot, Israel.
  • Lauriola M; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
  • Jacob-Hirsch J; Clinical Division of Oncology, Department of Medicine 1 and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Haibe-Kains B; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
  • Amariglio N; Department of Pediatric Hemato-Oncology and Functional Genomics, The Chaim Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Ben-Chetrit N; Institut Jules Bordet, Translational Research Unit, Brussels, Belgium.
  • Emde A; Machine Learning Group, Université Libre de Bruxelles, Brussels, Belgium.
  • Solomonov I; Department of Pediatric Hemato-Oncology and Functional Genomics, The Chaim Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Neufeld G; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
  • Piccart M; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
  • Sagi I; Department of Structural Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Sotiriou C; Cancer Research and Vascular Biology Center, The Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.
  • Rechavi G; Institut Jules Bordet, Translational Research Unit, Brussels, Belgium.
  • Domany E; Department of Structural Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Desmedt C; Institut Jules Bordet, Translational Research Unit, Brussels, Belgium.
  • Yarden Y; Department of Pediatric Hemato-Oncology and Functional Genomics, The Chaim Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Oncogene ; 43(17): 1317, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38418546
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article